Risk factors for methicillin-resistant Staphylococcus aureus (MRSA) infection in a Japanese geriatric hospital

Public Health
M WashioM Fujishima

Abstract

A case control study on MRSA infection was carried out, with the purpose of evaluating the effect of age, gender, hypoalbuminemia, the limitation of activities of daily living (ADL), the administration of antibiotics and the use of the new cephems which include third generation cephalosporins and monobactam and carbapenems, on the occurrence of MRSA infection among the inpatients in a geriatric hospital. From April 1991 to March 1994, 285 patients underwent a bacterial culture in the various clinical aspects. 118 patients were positive for MRSA, who were then used as cases while 167 patients who were negative for MRSA were used as controls. The level of serum albumin and the ADL score were lower in the MRSA group than in the non-MRSA group (P < 0.01) while the number of antibiotics administered before bacterial culture was greater in the MRSA group than in the non-MRSA group (P < 0.01). The third generation cephems were more commonly used in the MRSA positive patients than the negative patients (P < 0.01). Even after controlling for the other factors, hypoalbuminemia (OR = 1.73, 95% CI = 1.27-2.36), the limited ADL (partially limited vs without limitation: OR = 1.88, 95% CI = 1.19-2.96, completely limited vs without limitation:...Continue Reading

References

Feb 1, 1994·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·J M BoyceR Weinstein
Jan 14, 1961·British Medical Journal

❮ Previous
Next ❯

Citations

Mar 27, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·A D HarrisM H Samore
Apr 20, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Lisa S YoungLisa G Winston
May 6, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·David L Paterson
Mar 14, 2009·The Journal of Antimicrobial Chemotherapy·F Kate GouldUNKNOWN MRSA Working Party of the British Society for Antimicrobial Chemotherapy
Nov 1, 2006·Emerging Infectious Diseases·Louiselle LeBlancMarie-Eve Alary
Feb 7, 2015·Geriatrics & Gerontology International·Masakazu WashioUNKNOWN Kyushu Task Force for CAP Risk in the Elderly
Jun 13, 2009·Enfermedades infecciosas y microbiología clínica·Hiart MaortuaAlicia Labora
Sep 14, 1999·Journal of the American Geriatrics Society·Y Arai, M Washio
Sep 21, 2010·The Journal of Hospital Infection·H-R KimJ-J Yim
Jan 13, 2009·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Alexander L A BloemendaalJan Verhoef
Dec 18, 2001·Chest·P Eggimann, D Pittet
Oct 24, 2007·Journal of Oral and Maxillofacial Surgery : Official Journal of the American Association of Oral and Maxillofacial Surgeons·Minoru MiyakeShunichiro Nagahata
Mar 11, 2005·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Petra VovkoMarija Gubina
Feb 27, 2009·Medizinische Klinik·Fuat H SanerChristoph E Broelsch
Mar 2, 2006·The Journal of Antimicrobial Chemotherapy·Curtis G GemmellUNKNOWN Joint Working Party of the British Society for Joint Working Party of the British Society for Antimicrobial Chemotherapy, Ho
Mar 27, 1999·Archives of Environmental Health·R T BurnettJ R Brook
Sep 27, 2012·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·E Ghaznavi-RadA F Andar-Ali
Apr 7, 2004·The Journal of Hospital Infection·C MarshallD Spelman

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carbapenems

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Cell Aging (Keystone)

This feed focuses on cellular aging with emphasis on the mitochondria, autophagy, and metabolic processes associated with aging and longevity. Here is the latest research on cell aging.

Carbapenems (ASM)

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Related Papers

Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America
A B JessopS M Paul
Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America
Y L LeeL Thrupp
Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America
Paul J DrinkaKurt D Reed
© 2021 Meta ULC. All rights reserved